Back to top

Tale of the Tape

Zacks Equity Research

GW Pharmaceuticals plc (GWPH) Jumps: Stock Rises 7.6%
February 05, 2014


Trades from $3
GW Pharmaceuticals plc (GWPH - Free Report) was a big mover last session, as the company saw its shares rise by roughly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 55% in the past one-month time frame.

This drug manufacturer has seen one negative revision in the past 30 days and its Zacks Consensus Estimate moved lower over the time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

GW Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include NuVasive, Inc. (NUVA - Free Report) , Covidien plc and PositiveID Corporation . While NuVasive holds a Zacks Rank #1 (Strong Buy), Covidien and PositiveID carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

GW Pharmaceuticals PLC (GWPH) - free report >>

NuVasive, Inc. (NUVA) - free report >>